Cefpimizole
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| 2-[1-([(6R,7R)-2-carboxy-7-([(2R)-2-[(5-carboxy1H-imidazole-4-carbonyl)amino]-2-phenylacetyl]amino)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl)pyridin-1-ium-4-yl]ethanesulfonate | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ℞ Prescription only |
| Identifiers | |
| CAS number | 84880-03-5 |
| ATC code | None |
| PubChem | CID 11765031 |
| ChemSpider | 61863 |
| UNII | 24S58UHU7N |
| KEGG | D03427 |
| Chemical data | |
| Formula | C28H26N6O10S2 |
| Mol. mass | 670.67 g/mol |
|
|
|
|
| |
|
Cefpimizole (INN) is a third-generation cephalosporin antibiotic.
References[edit]
- Hara K, Shimada J (June 1987). "[New antimicrobial agent series XXI: Cefpimizole]". Jpn J Antibiot (in Japanese) 40 (6): 1108–22. PMID 3312705.
| This systemic antibacterial-related article is a stub. You can help Wikipedia by expanding it. |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||